These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9716900)

  • 1. Langerhans cell migration in murine cutaneous leishmaniasis: regulation by tumor necrosis factor alpha, interleukin-1 beta, and macrophage inflammatory protein-1 alpha.
    Arnoldi J; Moll H
    Dev Immunol; 1998; 6(1-2):3-11. PubMed ID: 9716900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1997 Apr; 289(5):277-84. PubMed ID: 9164638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunopharmacology; 1999 Apr; 41(3):235-43. PubMed ID: 10428652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses.
    Cumberbatch M; Dearman RJ; Groves RW; Antonopoulos C; Kimber I
    Toxicol Appl Pharmacol; 2002 Jul; 182(2):126-35. PubMed ID: 12140176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
    Cumberbatch M; Kimber I
    Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture.
    Heufler C; Topar G; Koch F; Trockenbacher B; Kämpgen E; Romani N; Schuler G
    J Exp Med; 1992 Oct; 176(4):1221-6. PubMed ID: 1402664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin.
    Enk AH; Angeloni VL; Udey MC; Katz SI
    J Immunol; 1993 May; 150(9):3698-704. PubMed ID: 8473727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 1997 Nov; 92(3):388-95. PubMed ID: 9486113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha).
    Kimber I; Cumberbatch M
    J Invest Dermatol; 1992 Nov; 99(5):48S-50S. PubMed ID: 1431209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha, RANTES, and MCP-1 are major chemoattractants of murine Langerhans cells to the regional lymph nodes.
    Yamazaki S; Yokozeki H; Satoh T; Katayama I; Nishioka K
    Exp Dermatol; 1998 Feb; 7(1):35-41. PubMed ID: 9517920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction by tumour necrosis factor alpha of dose-related changes in Langerhans cell frequency in mice.
    Cumberbatch M; Dearman RJ; Kimber I
    Arch Dermatol Res; 1999; 291(7-8):453-8. PubMed ID: 10482017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 2002 Apr; 105(4):466-77. PubMed ID: 11985667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice.
    Byrne SN; Halliday GM; Johnston LJ; King NJ
    J Invest Dermatol; 2001 Sep; 117(3):702-9. PubMed ID: 11564180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of UVA1 and UVB radiation on Langerhans cell migration in mice.
    Duthie MS; Kimber I; Dearman RJ; Norval M
    J Photochem Photobiol B; 2000 Sep; 57(2-3):123-31. PubMed ID: 11154078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H; Fuchs H; Blank C; Röllinghoff M
    Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism.
    Cumberbatch M; Dearman RJ; Antonopoulos C; Groves RW; Kimber I
    Immunology; 2001 Mar; 102(3):323-30. PubMed ID: 11298831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression.
    Takayama K; Yokozeki H; Ghoreishi M; Satoh T; Katayama I; Umeda T; Nishioka K
    J Invest Dermatol; 1999 Oct; 113(4):541-6. PubMed ID: 10504438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.
    Sato N; Ahuja SK; Quinones M; Kostecki V; Reddick RL; Melby PC; Kuziel WA; Ahuja SS
    J Exp Med; 2000 Jul; 192(2):205-18. PubMed ID: 10899907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.